These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2407916)

  • 21. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA; Teicher BA; McIntosh NL; Rose CM
    Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
    Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
    Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial.
    Haffty BG; Hurley R; Peters LJ
    Cancer J Sci Am; 1999; 5(6):341-7. PubMed ID: 10606475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.
    Dowell JE; Sinard R; Yardley DA; Aviles V; Machtay M; Weber RS; Weinstein GS; Chalian AA; Carbone DP; Rosenthal DI
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):97-101. PubMed ID: 10210547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
    Hishikawa-Itoh Y; Kato T; Niwa T; Ayakawa Y; Miyata N
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1243-8. PubMed ID: 2794648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
    Teicher BA; Rose CM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1311-3. PubMed ID: 3093415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluosol and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced non-small cell carcinoma of the lung: results of a phase I/II study.
    Lustig R; Lowe N; Prosnitz L; Spaulding M; Cohen M; Stitt J; Brannon R
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):97-102. PubMed ID: 2166021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors.
    Evans RG; Kimler BF; Morantz RA; Batnitzky S
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):649-52. PubMed ID: 8330996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluosol-DA as a red-cell substitute in acute anemia.
    N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of fluorocarbon emulsions in cancer radiotherapy.
    Guichard M
    Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen.
    Martin DF; Porter EA; Rockwell S; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1987 May; 13(5):747-51. PubMed ID: 3570898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluosol: therapeutic failure in severe anemia.
    Kale PB; Sklar GE; Wesolowicz LA; DiLisio RE
    Ann Pharmacother; 1993 Dec; 27(12):1452-4. PubMed ID: 8305774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.
    Vercellotti GM; Hammerschmidt DE; Craddock PR; Jacob HS
    Blood; 1982 Jun; 59(6):1299-1304. PubMed ID: 7082830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluosol-DA in radiation therapy.
    Lustig RA; McIntosh NL
    Prog Clin Biol Res; 1986; 211():29-38. PubMed ID: 3960931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.